Probelin

Probelin

clobetasol

Manufacturer:

Beximco

Distributor:

Medgenic Pharna

Marketer:

Euro Generics
Concise Prescribing Info
Contents
Clobetasol propionate
Indications/Uses
Treatment of more resistant dermatoses eg, psoriasis (excluding widespread plaque psoriasis), recalcitrant eczema & other conditions nonresponsive to less active steroids.
Dosage/Direction for Use
Apply small amount to the affected area once or bid. Discontinue therapy when control is achieved.
Contraindications
Hypersensitivity. Rosacea, acne vulgaris, perioral dermatitis, perianal & genital pruritus. Primary cutaneous viral infections (eg, herpes simplex, chickenpox). Childn <1 yr (dermatoses including dermatitis & napkin eruptions).
Special Precautions
Long-term therapy. Face may exhibit atrophic changes after prolonged treatment. Avoid contact w/ eyes. Risk of rebound relapses, development of tolerance & generalized pustular psoriasis for local & systemic toxicity (carefully monitor patient when used in psoriasis). Childn & infants. Pregnancy.
Adverse Reactions
Skin atrophy especially w/ occlusion or in skin folds, hypercorticism.
ATC Classification
D07AD01 - clobetasol ; Belongs to the class of very potent (group IV) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Probelin cream 0.05%
Packing/Price
10 g x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in